Boris Striepen

22PUBLICATIONS
74CO-AUTHORS
Medical infection agents (incl. prions)Major global burdens of diseaseCancer geneticsPublic health nutritionCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 01, 2026
Cryptosporidium sequentially remodels its single rhoptry into the host interface.

|May 13, 2026
Genomic heterogeneity of NAD(P)H dehydrogenase predisposes Cryptosporidium to clofazimine resistance.

|Nov 24, 2025
Widespread genomic heterogeneity at the type II NAD(P)H dehydrogenase locus predisposes Cryptosporidium to clofazimine resistance.

Gracyn Y Buenconsejo, Sebastian Shaw, Rui Xiao

|Jun 06, 2025
Genetic crosses reveal genomic loci responsible for virulence in Cryptosporidium parvum infection.

Sebastian Shaw, Xue Li, Gracyn Buenconsejo

|Jul 12, 2024
Cryptosporidium impacts epithelial turnover and is resistant to induced death of the host cell.

Bethan A Wallbank, Ryan D Pardy, Igor E Brodsky

|Jun 03, 2024
Intestinal cDC1s provide cues required for CD4+ T cell-mediated resistance to Cryptosporidium.

Ian S Cohn, Bethan A Wallbank, Breanne E Haskins

Pageof 4

Frequent Collaborators

5 joint publications

Sebastian Shaw

4 joint publications

Keenan M O'Dea

3 joint publications

Rui Xiao

3 joint publications

Yi-Wei Chang